- Home
- MDXH vs YI Comparison
MDXH vs YI Comparison
Compare MDXH & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- YI
- Stock Information
- Founded
- MDXH 2003
- YI 2010
- Country
- MDXH Belgium
- YI China
- Employees
- MDXH N/A
- YI N/A
- Industry
- MDXH
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- MDXH
- YI Consumer Staples
- Exchange
- MDXH Nasdaq
- YI Nasdaq
- Market Cap
- MDXH 84.6M
- YI 70.0M
- IPO Year
- MDXH 2021
- YI N/A
- Fundamental
- Price
- MDXH $2.18
- YI $7.48
- Analyst Decision
- MDXH Buy
- YI
- Analyst Count
- MDXH 1
- YI 0
- Target Price
- MDXH $6.00
- YI N/A
- AVG Volume (30 Days)
- MDXH 61.1K
- YI 12.6K
- Earning Date
- MDXH 08-20-2025
- YI 08-28-2025
- Dividend Yield
- MDXH N/A
- YI N/A
- EPS Growth
- MDXH N/A
- YI N/A
- EPS
- MDXH N/A
- YI N/A
- Revenue
- MDXH $94,507,000.00
- YI $1,984,717,013.00
- Revenue This Year
- MDXH $23.51
- YI N/A
- Revenue Next Year
- MDXH $17.68
- YI N/A
- P/E Ratio
- MDXH N/A
- YI N/A
- Revenue Growth
- MDXH 25.46
- YI N/A
- 52 Week Low
- MDXH $1.35
- YI $4.15
- 52 Week High
- MDXH $3.50
- YI $12.90
- Technical
- Relative Strength Index (RSI)
- MDXH 52.06
- YI 47.47
- Support Level
- MDXH $2.09
- YI $7.02
- Resistance Level
- MDXH $2.22
- YI $7.88
- Average True Range (ATR)
- MDXH 0.10
- YI 0.49
- MACD
- MDXH -0.01
- YI -0.01
- Stochastic Oscillator
- MDXH 59.52
- YI 55.35
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.